Bioleaders Corporation (142760) — Working Capital to Net Assets Ratio
Bioleaders Corporation (142760) has a Working Capital to Net Assets ratio of 33.3% as of March 2026. Working capital of ₩10.66 Billion (current assets of ₩21.47 Billion minus current liabilities of ₩10.82 Billion) is measured against net assets of ₩31.99 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how financially flexible is Bioleaders Corporation to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Bioleaders Corporation Working Capital to Net Assets (2015–2025)
This chart shows how Bioleaders Corporation's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of March 2026, the ratio stands at 33.3%, reflecting working capital of ₩10.66 Billion against net assets of ₩31.99 Billion KRW. See 142760 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Bioleaders Corporation (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Bioleaders Corporation from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 142760 market cap overview.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 49.3% | ₩15.06 Billion | ₩30.57 Billion | ₩26.52 Billion | ₩11.46 Billion | ▼ -19.7 pp |
| 2024 | 69.0% | ₩25.74 Billion | ₩37.31 Billion | ₩46.37 Billion | ₩20.63 Billion | ▲ +20.6 pp |
| 2023 | 48.4% | ₩17.31 Billion | ₩35.79 Billion | ₩29.84 Billion | ₩12.53 Billion | ▲ +17.0 pp |
| 2022 | 31.4% | ₩6.80 Billion | ₩21.69 Billion | ₩71.77 Billion | ₩64.97 Billion | ▼ -80.4 pp |
| 2021 | 111.8% | ₩50.44 Billion | ₩45.11 Billion | ₩97.14 Billion | ₩46.70 Billion | ▲ +78.3 pp |
| 2020 | 33.5% | ₩10.26 Billion | ₩30.60 Billion | ₩73.53 Billion | ₩63.26 Billion | ▲ +17.9 pp |
| 2019 | 15.7% | ₩3.73 Billion | ₩23.82 Billion | ₩66.55 Billion | ₩62.82 Billion | ▲ +52.0 pp |
| 2018 | -36.3% | ₩-8.54 Billion | ₩23.50 Billion | ₩69.23 Billion | ₩77.77 Billion | ▼ -118.7 pp |
| 2017 | 82.4% | ₩28.96 Billion | ₩35.17 Billion | ₩30.91 Billion | ₩1.94 Billion | ▼ -0.5 pp |
| 2016 | 82.9% | ₩14.47 Billion | ₩17.46 Billion | ₩17.67 Billion | ₩3.20 Billion | ▲ +2.8 pp |
| 2015 | 80.1% | ₩4.45 Billion | ₩5.55 Billion | ₩7.90 Billion | ₩3.45 Billion | — |